Welcome to Drug Target Review. This site uses cookies. Read our policy.

  • Skip to main content
  • Skip to navigation
Site name
Site name
Mast navigation
  • Become a member
  • Sign In
Search our site
Menu
Close menu
  • Home
  • News
  • Oncology
  • AI
  • Topics
    • Back to parent navigation item
    • Topics
    • Technology
    • Resources
    • Diseases
    • Drugs and therapies
    • Research and development
    • Tools and techniques
    • Business
  • Webinars
  • Whitepapers
  • Reports
  • Home
  • News
  • Oncology
  • AI
  • Topics
      • Technology
      • Resources
      • Diseases
      • Drugs and therapies
      • Research and development
      • Tools and techniques
      • Business
    • Cell,Culture,With,Multichannel,Pipettes
      Designing targeted assays for clinical success from the start
    • Medical,Scientist,Loading,Samples,In,Robot,Machine,For,Biochemical,Automatic
      Discovery is changing – and automation leads the way
    • Image
      World ADC 2026: where antibody-drug conjugates are heading
  • Webinars
  • Whitepapers
  • Reports
  • More navigation items

A to Z subjects

Find stories by subject. Use the A-Z options to view other subjects.

  • A to Z subjects
  • A to Z contributors
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
  • 0-9
  • All
E
  • Ebola
  • Ecole Polytechnique Fédérale De Lausanne (EPFL)
  • Eczema
  • Edinburgh University
  • Editorial
  • Edmond Chan
  • Efficacy Testing
  • Eindhoven University of Technology (TU Eindhoven)
  • Eisei Sohara (Associate Professor at Science Tokyo)
  • Element Biosciences
  • ElevateBio
  • Eli Lilly
  • Eli Lilly and Company
  • Eli Pollock (Co-founder of Ontologic)
  • Elicio Therapeutics
  • ELRIG
  • Elsevier
  • Emervax
  • Emma Glass
  • Emory University
  • Endocrine disorders
  • endometriosis
  • Enedra Therapeutics
  • Enhanced Genomics
  • Enterprise Therapeutics Ltd
  • Enthera Pharmaceuticals
  • entX
  • Enzymes
  • EPFL
  • Epigenetics
  • Epileptic conditions
  • Erasmus MC
  • Ergodic
  • Eric Bennett (Founder and CEO of Frontier Bio)
  • Eric Ma (Senior Principal Data Scientist - Moderna)
  • Eric Zimmerman
  • Erik Digman Wiklund (CEO of Circio)
  • Erwin Estigarribia (CEO of Headlamp Health)
  • Escherichia coli
  • Esperion Therapeutics
  • Estela Sasso-Cerri (Professor at FOAr-UNESP)
  • eterna therapeutics
  • ETH Zurich
  • Etheros Pharmaceuticals Corp
  • Euretos
  • Eurofins DiscoverX
  • Eurofins Healthcare Assurance
  • European Association for the Study of Diabetes (EASD)
  • European Laboratory Research & Innovation Group (ELRIG) UK
  • European Research Council (ERC)
  • European Society of Endocrinology (ESE)
  • European University-Cyprus
  • Every Cure
  • evitria
  • Evotec
  • Ex Vivo Models
  • Exscientia
  • Eye Diseases
  • Topics
  • Technology
  • Resources
  • Diseases
  • Drugs and therapies
  • Research and development
  • Tools and techniques
  • Business
  • Advertising & Editorial
  • Advertising opportunities
  • Media planner
  • Advertising tech specs
  • Information for authors
  • Reuse policy
  • Information
  • About us
  • Company information
  • Careers
  • Terms and conditions
  • Privacy policy
  • Cookie policy
The trusted voice in drug discovery
Find us on social media:
  • Topics A-Z
  • Writers A-Z
  • © 2026 Drug Target Review

Site powered by Webvision Cloud